Prospective virome analyses in young children at increased genetic risk for type 1 diabetes - PubMed
. 2019 Dec;25(12):1865-1872.
doi: 10.1038/s41591-019-0667-0. Epub 2019 Dec 2.
Kristian F Lynch 2 , Matthew C Wong 3 , Xiangjun Tian 3 , Matthew C Ross 3 , Richard A Gibbs 4 , Nadim J Ajami 3 , Joseph F Petrosino 3 , Marian Rewers 5 , Jorma Toppari 6 7 , Anette G Ziegler 8 9 10 , Jin-Xiong She 11 , Ake Lernmark 12 , Beena Akolkar 13 , William A Hagopian 14 , Desmond A Schatz 15 , Jeffrey P Krischer 2 , Heikki Hyöty 16 17 , Richard E Lloyd 3 ; TEDDY Study Group
Affiliations
- PMID: 31792456
- PMCID: PMC6898786
- DOI: 10.1038/s41591-019-0667-0
Prospective virome analyses in young children at increased genetic risk for type 1 diabetes
Kendra Vehik et al. Nat Med. 2019 Dec.
Abstract
Viruses are implicated in autoimmune destruction of pancreatic islet β cells, which results in insulin deficiency and type 1 diabetes (T1D)1-4. Certain enteroviruses can infect β cells in vitro5, have been detected in the pancreatic islets of patients with T1D6 and have shown an association with T1D in meta-analyses4. However, establishing consistency in findings across studies has proven difficult. Obstacles to convincingly linking RNA viruses to islet autoimmunity may be attributed to rapid viral mutation rates, the cyclical periodicity of viruses7 and the selection of variants with altered pathogenicity and ability to spread in populations. β cells strongly express cell-surface coxsackie and adenovirus receptor (CXADR) genes, which can facilitate enterovirus infection8. Studies of human pancreata and cultured islets have shown significant variation in enteroviral virulence to β cells between serotypes and within the same serotype9,10. In this large-scale study of known eukaryotic DNA and RNA viruses in stools from children, we evaluated fecally shed viruses in relation to islet autoimmunity and T1D. This study showed that prolonged enterovirus B rather than independent, short-duration enterovirus B infections may be involved in the development of islet autoimmunity, but not T1D, in some young children. Furthermore, we found that fewer early-life human mastadenovirus C infections, as well as CXADR rs6517774, independently correlated with islet autoimmunity.
Conflict of interest statement
Competing Interests
H.H. is a shareholder and chairman of the Board of Vactech Ltd. and member of the Scientific Advisory Board of Provention Bio, Inc., which develop vaccines against picornaviruses and coxsackievirus B. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from the disclosed.
Figures

Extended Data Figure 1 (Panels a-d). Percentage of stool samples at age of first appearance of Enterovirus B. Panel a shows sample positivity and Panel b sample consecutive positivity. Panels c and d show months prior to autoantibody seroconversion of Enterovirus B for sample positivity (c) and sample consecutive positivity (d) by autoantibody case status (n=383 matched pair children). Blue line represents control samples and red line represents case samples. The timing of the first appearance of an Enterovirus B infection from enrollment (3 months of age) or months prior to islet autoimmunity showed no obvious trend by age of child.

Extended Data Figure 2 (Panels a-c). Common human viruses related to type 1 diabetes. The three forest plots (a-c) show how common human viruses relate to the odds of children being diagnosed with T1D. The results were shown as odds ratios (OR, circle) and 95% confidence intervals (CI, bars) and were calculated using conditional logistic regression models with adjustment for HLA-DR-DQ genotype. OR>1 indicated a positive correlation between virus pattern and diagnosis with T1D, OR<1 indicated an inverse correlation. Plot (a) examined if an increase in the number of samples positive for virus was correlated with T1D (n=112 matched pair children). Plot (b) examined if children positive for the virus between 3 and 6 months of age were related to T1D (n=103 matched pair children). Plot (c) examined if children positive for the common virus in at least two consecutive samples (yes versus no) were related to T1D (n=112 matched pair children). Black circles and CI bars represent non-significant associations. Red circles and CI bars represent significant association with T1D. The number of positive stool samples for Enterovirus B was lower among T1D cases compared to matched controls. Human mastadenovirus C, similar to islet autoimmunity cases, was less likely to be detected in early stool samples (3–6 months of age) compared to the matched control for T1D cases. All p-values were two-sided.

Extended Data Figure 3. Heatmaps of contig alignments of successive stools (n=6 children). Heatmaps showing percent homology of alignments of enterovirus contigs isolated from successive stools from the same child. Stool collection date (successive days in the study) are shown, the serotype for the enterovirus aligned, all are aligned to an enterovirus genome map with scale of nucleotides at the bottom. Heatmap color is assigned on ~7 nt/pixel, heatmap color scale of percent homology is shown at the top.

Extended Data Figure 4. Children consecutive positive for Enterovirus B with prolonged shedding of same serotype. Categorical months of shedding by number of children for islet autoimmunity cases (n=45) and controls (n=25). Red bars denote cases and blue bars denote controls. Length of prolonged shedding period (duration) was not associated with case status in the children with consecutive positive Enterovirus B. Conditional logistic regression was used to evaluate significance; test was two-sided.

The pie chart (a) indicates the relative proportion of major classes of viruses found in the stool virome (n=5,725 samples, % positive overall, combined primary and cultured stools) in the first three years of life. Bar graphs indicate the estimated prevalence in the TEDDY cohort (n=6,890 children observed at risk for islet autoimmunity and type 1 diabetes up to 36 months of age) of the 20 most abundant mammalian viruses (b) and enterovirus serotypes found among the two most abundant enterovirus species (Enterovirus A, Enterovirus B) within the same stool dataset (c). The cohort prevalence were estimated by weighting the proportion of stool samples that were positive for the virus to account for how the children were selected as controls (n=495) into the two nested-matched case-control studies. The three forest plots (d-f) show how common human viruses relate to the odds of developing islet autoimmunity. The results were shown as odds ratios (OR, circle) and 95% confidence intervals (CI, bars) and were calculated using conditional logistic regression models with adjustment for HLA-DR-DQ genotype. All p-values were two-sided. OR>1 indicated a positive correlation between virus pattern and development of islet autoimmunity, OR<1 indicated an inverse correlation. Plot (d) examined if an increase in the number of samples positive for virus (n=4,327 matched pair samples) correlated with islet autoimmunity. Plot (e) examined if children positive for the virus between age 3 and 6 months (n=370 matched pair children) were related to islet autoimmunity. Plot (f) examined if children positive for the common virus in at least two consecutive samples (n=383 matched pair children) were related to islet autoimmunity. Black circles and CI bars represent non-significant associations. Red circles and CI bars represent statistical significant association for the a prior enterovirus at p<0.05 or for other viruses that showed a false discovery rate (FDR) at <0.05.

Panels a-d show the percentage positive for virus between ages 3 and 6 months (Panel a – Enterovirus A (EV-A), Panel b – Enterovirus B (EV-B), Panel c – Human mastadenovirus C (HAdV-C), and Panel d – Human mastadenovirus F (HAdV-F)). Panels e-h show the percentage consecutive positive before islet autoimmunity (Panel e – EV-A, Panel f – EV-B, Panel g – HAdV-C, and Panel h – HAdV-F). The red and blue bars represent cases and matched controls (by clinical site, gender and family history of type 1 diabetes), respectively. The darker color show the percentage of children positive for virus pattern with matching child negative. The light blue and red bars represent percentage of children positive for virus pattern with a concordant result in the matching child. Specifically, dark blue denotes control is positive for the virus pattern and matching case is negative. Light blue denotes both control and matching case are positive for virus pattern. Dark red denotes case is positive for virus pattern and matching pair control is negative. Light red denotes both case and matching control are positive for virus pattern. Asterisk (*) denotes statistically significant difference overall of discordant cases positive for virus (dark red) compared to discordant controls positive for virus (dark blue) across clinical sites (matched pair children in US-Colorado, n=55; US-Georgia/Florida, n=28; US-Washington, n=36; Finland, n=104; Germany, n=31; and, Sweden, n=129). Significance was assessed using conditional logistic regression adjusted for HLA-DR-DQ genotype. All p-values are two-sided.

The pattern groups were the following: 1) child was negative for EV-B (reference group), 2) child had a single sample positive for EV-B, 3) child had multiple, independent, non-consecutive samples positive for EV-B, 4) child had consecutive EV-B, but with unconfirmed prolonged shedding, and 5) child had multiple and prolonged shedding of the same EV-B serotype. Consecutive positive allowed for no more than one missed monthly stool sample. Odds ratios (OR, circle) and 95% confidence intervals (CI, bars) were calculated using conditional logistic regression models with adjustment for HLA-DR-DQ genotype. All p-values were two-sided.

The model shown in figure includes HLA-DR-DQ genotype, a single nucleotide polymorphism (SNP) in PTPN22, INS, ERBB3 and SH2B3 (all previously reported associated with islet autoimmunity in the TEDDY cohort and confirmed associated with islet autoimmunity in this nested-matched case-control study), a SNP in the Coxsackie and adenovirus receptor gene (CXADR), prolonged shedding or consecutive positive samples for EV-B, HAdV-C detected in stool samples up to age 6 months and number of HAdV-F detected in stools during follow-up, on islet autoimmunity case status. In addition, the model included the first two principal components describing ancestry and a propensity score for a stool to be EV-B positive. Odds ratios (black circle), 95% confidence intervals bars, and test of significant difference between cases and matched controls are estimated from multivariable conditional logistic regression model. All p-values are two-sided.
Similar articles
-
Ylipaasto P, Klingel K, Lindberg AM, Otonkoski T, Kandolf R, Hovi T, Roivainen M. Ylipaasto P, et al. Diabetologia. 2004 Feb;47(2):225-39. doi: 10.1007/s00125-003-1297-z. Epub 2004 Jan 15. Diabetologia. 2004. PMID: 14727023
-
Honkanen H, Oikarinen S, Nurminen N, Laitinen OH, Huhtala H, Lehtonen J, Ruokoranta T, Hankaniemi MM, Lecouturier V, Almond JW, Tauriainen S, Simell O, Ilonen J, Veijola R, Viskari H, Knip M, Hyöty H. Honkanen H, et al. Diabetologia. 2017 Mar;60(3):424-431. doi: 10.1007/s00125-016-4177-z. Epub 2017 Jan 9. Diabetologia. 2017. PMID: 28070615
-
Witsø E, Tapia G, Cinek O, Pociot FM, Stene LC, Rønningen KS. Witsø E, et al. PLoS One. 2011;6(11):e27781. doi: 10.1371/journal.pone.0027781. Epub 2011 Nov 14. PLoS One. 2011. PMID: 22110759 Free PMC article.
-
Stene LC, Rewers M. Stene LC, et al. Clin Exp Immunol. 2012 Apr;168(1):12-23. doi: 10.1111/j.1365-2249.2011.04555.x. Clin Exp Immunol. 2012. PMID: 22385232 Free PMC article. Review.
-
Immunopathology of the human pancreas in type-I diabetes.
Richardson SJ, Willcox A, Bone AJ, Morgan NG, Foulis AK. Richardson SJ, et al. Semin Immunopathol. 2011 Jan;33(1):9-21. doi: 10.1007/s00281-010-0205-0. Epub 2010 Apr 28. Semin Immunopathol. 2011. PMID: 20424842 Review.
Cited by
-
Zhao LP, Papadopoulos GK, Kwok WW, Moustakas AK, Bondinas GP, Carlsson A, Elding Larsson H, Ludvigsson J, Marcus C, Samuelsson U, Wang R, Pyo CW, Nelson WC, Geraghty DE, Lernmark Å. Zhao LP, et al. Diabetes. 2020 Nov;69(11):2523-2535. doi: 10.2337/db20-0374. Epub 2020 Aug 31. Diabetes. 2020. PMID: 32868339 Free PMC article.
-
Type 1 Diabetes: Interferons and the Aftermath of Pancreatic Beta-Cell Enteroviral Infection.
Akhbari P, Richardson SJ, Morgan NG. Akhbari P, et al. Microorganisms. 2020 Sep 15;8(9):1419. doi: 10.3390/microorganisms8091419. Microorganisms. 2020. PMID: 32942706 Free PMC article. Review.
-
Type 1 diabetes mellitus: much progress, many opportunities.
Powers AC. Powers AC. J Clin Invest. 2021 Apr 15;131(8):e142242. doi: 10.1172/JCI142242. J Clin Invest. 2021. PMID: 33759815 Free PMC article. Review.
-
Oakey H, Giles LC, Thomson RL, Lê Cao KA, Ashwood P, Brown JD, Knight EJ, Barry SC, Craig ME, Colman PG, Davis EA, Hamilton-Williams EE, Harrison LC, Haynes A, Kim KW, Mallitt KA, McGorm K, Morahan G, Rawlinson WD, Sinnott RO, Soldatos G, Wentworth JM, Couper JJ, Penno MAS; ENDIA Study Group. Oakey H, et al. Ann Med. 2023 Dec;55(1):2198255. doi: 10.1080/07853890.2023.2198255. Ann Med. 2023. PMID: 37043275 Free PMC article.
-
Fignani D, Licata G, Brusco N, Nigi L, Grieco GE, Marselli L, Overbergh L, Gysemans C, Colli ML, Marchetti P, Mathieu C, Eizirik DL, Sebastiani G, Dotta F. Fignani D, et al. Front Endocrinol (Lausanne). 2020 Nov 13;11:596898. doi: 10.3389/fendo.2020.596898. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 33281748 Free PMC article.
References
-
- van der Werf N, Kroese FGM, Rozing J & Hillebrands JL Viral infections as potential triggers of type 1 diabetes. Diabetes-Metab Res 23, 169–183 (2007). - PubMed
-
- Laitinen OH, et al. Coxsackievirus B1 is associated with induction of beta-cell autoimmunity that portends type 1 diabetes. Diabetes 63, 446–455 (2014). - PubMed
-
- Anagandula M, et al. Infection of human islets of Langerhans with two strains of Coxsackie B virus serotype 1: assessment of virus replication, degree of cell death and induction of genes involved in the innate immunity pathway. J Med Virol 86, 1402–1411 (2014). - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- U01 DK063821/DK/NIDDK NIH HHS/United States
- UC4 DK063863/DK/NIDDK NIH HHS/United States
- UL1 TR002535/TR/NCATS NIH HHS/United States
- HHSN267200700014C/DK/NIDDK NIH HHS/United States
- U01 DK063861/DK/NIDDK NIH HHS/United States
- U01 DK063790/DK/NIDDK NIH HHS/United States
- UL1 TR001082/TR/NCATS NIH HHS/United States
- UL1 TR000064/TR/NCATS NIH HHS/United States
- HHSN267200700014C/LM/NLM NIH HHS/United States
- U01 DK063836/DK/NIDDK NIH HHS/United States
- U01 DK063829/DK/NIDDK NIH HHS/United States
- U01 DK063865/DK/NIDDK NIH HHS/United States
- UC4 DK095300/DK/NIDDK NIH HHS/United States
- UC4 DK063861/DK/NIDDK NIH HHS/United States
- UC4 DK063829/DK/NIDDK NIH HHS/United States
- UC4 DK063821/DK/NIDDK NIH HHS/United States
- UC4 DK117483/DK/NIDDK NIH HHS/United States
- UC4 DK063836/DK/NIDDK NIH HHS/United States
- UC4 DK112243/DK/NIDDK NIH HHS/United States
- UC4 DK063865/DK/NIDDK NIH HHS/United States
- U01 DK063863/DK/NIDDK NIH HHS/United States
- UC4 DK106955/DK/NIDDK NIH HHS/United States
- UC4 DK100238/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical